Marijuana extract reduces seizures in patients with Lennox-Gastaut Syndrome in clinical trial.
GW Pharmaceuticals, the maker of a marijuana-based drug used to help children with rare forms of epilepsy, announced successful clinical trials of the drug Epidiolex in the treatment of Lennox-Gastaut Syndrome (LGS).
Epidiolex is made from pharmaceutical-grade cannabidiol (CBD) oil, a nonpsychoactive compound extracted from the cannabis plant.
In this randomized, double-blind, placebo-controlled Phase 3 clinical trial of the drug, Epidiolex was found to successfully reduce seizures in patients with LGS, a rare and severe form of epilepsy that develops in childhood.
Click here to read the complete article
Emily Gray Brosious ~ ExtractSunTmes.com ~
